Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: Assessment by urodynamic studies

The Prostate

Volumn 25, Issue 1, 1994, Pages 46-52

  Yasuda, Kosaku ^a   Yamanishi, Tomonori ^a   Tojo, Masaki ^a   Nagashima, Kaoru ^a   Akimoto, Susumu ^a   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

benign prostatic hyperplasia; naftopidil; urodynamic study

Indexed keywords

NAFTOPIDIL;

ADULT; AGED; ARTICLE; BLADDER PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; URETHRA OBSTRUCTION; URINE FLOW RATE; URODYNAMICS; VERTIGO;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; HUMAN; MALE; MIDDLE AGE; NAPHTHALENES; PIPERAZINES; PROSTATIC HYPERPLASIA; TREATMENT OUTCOME; URETHRAL OBSTRUCTION; URINE; URODYNAMICS;

EID: 0028098797     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.2990250107     Document Type: Article

References (16)

1. Dynamics of acute retention in prostatic patient and role of adrenergic receptors
2. Change of external urethral sphincter function in prostatic patients
3. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck
4. Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue
5. Alpha‐adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy
6. A placebo‐controlled double‐blind study of the effect of phenoxybenzamine in benign prostatic obstruction
7. Prazosin in the treatment of prostatic obstruction, a placebo‐controlled study
8. The effect of prazosin in benign prostatic hypertrophy, a placebo controlled double‐blind study
9. The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia
10. 1‐blocker, YM617, in the treatment of benign prostatic hypertrophy
11. The urethral pressure profile
12. The diagnosis of prostatic obstruction by measurement of urethral resistance to flow
13. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation
14. Alpha‐adrenoceptors and muscarinic receptors in the isolated human prostate
15. The present role of alpha‐adrenergic blockers in the treatment of benign prostatic hypertrophy
16. Uninhibited neurogenic bladder treated with prazosin